Goelzer Investment Management, Inc. Merck & Co., Inc. Transaction History

Goelzer Investment Management, Inc.

$1.81 Billion
Q3 2024

A detailed history of Goelzer Investment Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Goelzer Investment Management, Inc. holds 134,005 shares of MRK stock, worth $12.9 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

134,005

Previous 135,359 1.0%

Holding current value

$12.9 Million

Previous $16.8 Million 9.19%

% of portfolio

0.84%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$111.15 - $128.97 $150,497 - $174,625	-1,354 Reduced 1.0%	134,005 $15.2 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $227,296 - $244,114	-1,836 Reduced 1.34%	135,359 $16.8 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $496,670 - $578,732	-4,386 Reduced 3.1%	137,195 $18.1 Million
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $128,230 - $139,545	-1,280 Reduced 0.9%	141,581 $15.4 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $307,202 - $341,160	-2,984 Reduced 2.05%	142,861 $14.7 Million
Q2 2023 Jul 26, 2023	SELL	$108.61 - $118.38 $1.14 Million - $1.25 Million	-10,539 Reduced 6.74%	145,845 $16.8 Million
Q1 2023 Apr 27, 2023	SELL	$102.94 - $114.86 $1.29 Million - $1.44 Million	-12,569 Reduced 7.44%	156,384 $16.6 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $197,614 - $253,368	-2,260 Reduced 1.32%	168,953 $0
Q3 2022 Nov 10, 2022	BUY	$84.53 - $94.96 $240,656 - $270,351	2,847 Added 1.69%	171,213 $14.7 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $299,144 - $339,095	3,583 Added 2.17%	168,366 $15.4 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $123,643 - $138,596	-1,682 Reduced 1.01%	164,783 $13.5 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $177,736 - $222,637	-2,459 Reduced 1.46%	166,465 $12.8 Million
Q3 2021 Oct 29, 2021	SELL	$71.68 - $78.83 $354,027 - $389,341	-4,939 Reduced 2.84%	168,924 $12.7 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $1.76 Million - $1.94 Million	24,968 Added 16.77%	173,863 $13.5 Million
Q1 2021 May 06, 2021	BUY	$68.86 - $81.11 $839,541 - $988,893	12,192 Added 8.92%	148,895 $11.5 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $1.57 Million - $1.74 Million	-21,865 Reduced 13.79%	136,703 $11.2 Million
Q3 2020 Oct 27, 2020	SELL	$73.18 - $82.95 $81,961 - $92,904	-1,120 Reduced 0.7%	158,568 $13.2 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $6,689 - $7,612	95 Added 0.06%	159,688 $12.3 Million
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $1.71 Million - $2.37 Million	-27,016 Reduced 14.48%	159,593 $12.3 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $22,420 - $25,299	-289 Reduced 0.15%	186,609 $17 Million
Q3 2019 Nov 06, 2019	SELL	$76.08 - $82.93 $31,040 - $33,835	-408 Reduced 0.22%	186,898 $15.7 Million
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $45,815 - $53,523	656 Added 0.35%	187,306 $15.7 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $50,862 - $58,012	-731 Reduced 0.39%	186,650 $15.5 Million
Q4 2018 Jan 28, 2019	SELL	$65.24 - $75.71 $37,708 - $43,760	-578 Reduced 0.31%	187,381 $14.3 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $63,228 - $74,352	-1,096 Reduced 0.58%	187,959 $13.3 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $86,106 - $101,165	1,694 Added 0.9%	189,055 $11.5 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $1.41 Million - $1.64 Million	27,661 Added 17.32%	187,361 $10.2 Million
Q4 2017 Feb 06, 2018	BUY	$51.62 - $61.64 $148,768 - $177,646	2,882 Added 1.84%	159,700 $8.99 Million
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $9.2 Million - $9.9 Million	156,818	156,818 $10 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Goelzer Investment Management, Inc. with notifications on news.

Account

Goelzer Investment Management, Inc. Merck & Co., Inc. Transaction History